Chimeric Antigen Receptor T Cell therapy
Reprogramming our T cell product candidates
An emergence of a new treatment
For many years, the cornerstones of cancer treatment have been surgery, chemotherapy and radiation therapy.
Recent years have seen the emergence of cancer immunotherapy, in which treatments harness the power of a patient’s immune system to combat their disease.
T cells are a type of white blood cell that form part of the immune system’s natural protection against cancer and infection. Normally our T cells can detect and eliminate abnormal or cancerous cells but sometimes these cells can escape detection and develop into tumors.
To overcome this problem Autolus is applying its advanced cell programming technologies and specialized manufacturing processes to develop programming T cell product candidates.
